Associate Director, Advanced Analytics & AI Enablement
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Director, US Commercial Analytics, the Associate Director, Advanced Analytics & AI Enablement will own the specialist predictive and causal methods that improve targeting, promotional investment, and commercial decisions across Revolution Medicines' portfolio. As RevMed prepares for overlapping launches across multiple cancers, many priority HCPs are likely to be relevant to more than one brand, making it essential to determine which customers to prioritize, for which brands, and at what l
